With a background steeped in biopharmaceutical innovation, Ivan Kairatov is a leading expert in oncology therapeutics. His insights into the development and approval of new cancer treatments are invaluable, especially regarding the European Commission's recent decision on AstraZeneca's Calquence
Recent European Union regulations have significantly reshaped the clinical trials landscape, positioning compliance as a competitive advantage for biopharmaceutical firms. With frameworks such as the EU General Data Protection Regulation (GDPR), the Artificial Intelligence (AI) Act, and the
The integrity of clinical trials remains an ever-present concern within the medical and scientific communities. One of the most pressing issues threatening this integrity is the participation of duplicate and professional research subjects. These individuals, who simultaneously or successively
Navigating the intricate landscape of healthcare demands more than just clinical expertise, as illustrated by the Health Service Executive (HSE) consultants grappling with the dual demands of stringent training requirements and clinical obligations. This challenge was vividly brought to light
In an era where personal data is often treated as a commodity, New Mexico's recent initiative seeks to offer a robust shield against potential misuse and exploitation. Launched by the New Mexico Community & Health Information Safety & Privacy Advocacy (NMCHISPA), this campaign highlights the
The burgeoning demands of the healthcare industry have put the spotlight on sterile packaging, a pivotal element in ensuring the safety and efficacy of medical products and devices. As healthcare facilities worldwide grapple with escalating cases of chronic diseases, the need for impeccable
